Nektar Therapeutics | NKTR - Operating Profit


Nektar Therapeutics reported $-38.26M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Agios Pharmaceuticals USD -110.02M 11.55M Mar/2026
ALKERMES USD -65.93M 17.65M Jun/2026
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Amgen USD 4.61B 777M Jun/2026
Baxter International USD 276M 210M Jun/2026
BioCryst Pharmaceuticals USD 98.46M 161.92M Jun/2026
Biogen USD -243.8M 758.1M Jun/2026
Bristol-Myers Squibb USD 299M 3.07B Jun/2026
Cara Therapeutics USD -7.05M 1.11M Mar/2026
Cipla INR 8.88B 2.74B Jun/2026
Dr.Reddys Laboratories INR 3.25B 2.36B Jun/2026
Eisai JPY 24.73B 35.04B Jun/2026
Eli Lilly USD 12.46B 2.68B Jun/2026
Exelixis USD 248.41M 2.93M Jun/2026
Gilead Sciences USD 3.85B 1.17B Jun/2026
GlaxoSmithKline GBP 2.6B 312M Jun/2026
Grifols EUR 320.55M 91.01M Dec/2025
Halozyme Therapeutics USD -63.72M 1.95M Jun/2026
Incyte USD 700.4M 376.22M Jun/2026
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
Karyopharm Therapeutics USD -26.76M 8.92M Mar/2026
MacroGenics USD -33.44M 21.34M Mar/2026
Merck USD 840M 2.72B Jun/2026
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Neurocrine Biosciences USD 219.9M 5.3M Jun/2026
Novartis USD 4.75B 515M Jun/2026
Pfizer USD 667M 4.32B Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sarepta Therapeutics USD 13.29M 345.14M Jun/2026
Takeda JPY 201.42B 215.04B Jun/2026
Teva Pharmaceutical Industries USD 235M 523M Jun/2026
Xencor USD -36.6M 41.26M Jun/2026